These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23610125)

  • 1. In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.
    Pichiorri F; Palmieri D; De Luca L; Consiglio J; You J; Rocci A; Talabere T; Piovan C; Lagana A; Cascione L; Guan J; Gasparini P; Balatti V; Nuovo G; Coppola V; Hofmeister CC; Marcucci G; Byrd JC; Volinia S; Shapiro CL; Freitas MA; Croce CM
    J Exp Med; 2013 May; 210(5):951-68. PubMed ID: 23610125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer.
    Yan Y; Narayan A; Cho S; Cheng Z; Liu JO; Zhu H; Wang G; Wharram B; Lisok A; Brummet M; Saeki H; Huang T; Gabrielson K; Gabrielson E; Cope L; Kanaan YM; Afsari A; Naab T; Yfantis HG; Ambs S; Pomper MG; Sukumar S; Merino VF
    Oncogene; 2021 Sep; 40(38):5752-5763. PubMed ID: 34341513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.
    Li P; Xu T; Zhou X; Liao L; Pang G; Luo W; Han L; Zhang J; Luo X; Xie X; Zhu K
    Cancer Med; 2017 Mar; 6(3):662-672. PubMed ID: 28220627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation.
    Iturriaga-Goyon E; Vivanco-Rojas O; Magaña-Guerrero FS; Buentello-Volante B; Castro-Salas I; Aguayo-Flores JE; Gracia-Mora I; Rivera-Huerta M; Sánchez-Bartés F; Garfias Y
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.
    Rao X; Di Leva G; Li M; Fang F; Devlin C; Hartman-Frey C; Burow ME; Ivan M; Croce CM; Nephew KP
    Oncogene; 2011 Mar; 30(9):1082-97. PubMed ID: 21057537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of nucleolin expression by miR-194, miR-206, and HuR.
    Bose S; Tholanikunnel TE; Reuben A; Tholanikunnel BG; Spicer EK
    Mol Cell Biochem; 2016 Jun; 417(1-2):141-53. PubMed ID: 27221739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AS1411 binds to nucleolin via its parallel structure and disrupts the exos-miRNA-27a-mediated reciprocal activation loop between glioma and astrocytes.
    Sun X; Zhang W; Gou C; Wang X; Wang X; Shao X; Chen X; Chen Z
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167211. PubMed ID: 38701957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
    Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
    PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
    Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
    J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transcriptional regulation of MMP2 mRNA by its interaction with miR-20a and Nucleolin in breast cancer cell lines.
    Das S; De S; Sengupta S
    Mol Biol Rep; 2021 Mar; 48(3):2315-2324. PubMed ID: 33788053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer.
    Li L; Wei D; Zhang J; Deng R; Tang J; Su D
    Comput Math Methods Med; 2022; 2022():5203839. PubMed ID: 35069784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.
    Yan LX; Wu QN; Zhang Y; Li YY; Liao DZ; Hou JH; Fu J; Zeng MS; Yun JP; Wu QL; Zeng YX; Shao JY
    Breast Cancer Res; 2011 Jan; 13(1):R2. PubMed ID: 21219636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico study predicts a key role of RNA-binding domains 3 and 4 in nucleolin-miRNA interactions.
    San A; Palmieri D; Saxena A; Singh S
    Proteins; 2022 Nov; 90(11):1837-1850. PubMed ID: 35514080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
    Croset M; Pantano F; Kan CWS; Bonnelye E; Descotes F; Alix-Panabières C; Lecellier CH; Bachelier R; Allioli N; Hong SS; Bartkowiak K; Pantel K; Clézardin P
    Cancer Res; 2018 Sep; 78(18):5259-5273. PubMed ID: 30042152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Profiling of Transgenic Mice with Myocardial Overexpression of Nucleolin.
    Lyu QL; Jiang BM; Zhou B; Sun L; Tong ZY; Li YB; Tang YT; Sun H; Liu MD; Xiao XZ
    Chin Med J (Engl); 2018 Feb; 131(3):339-346. PubMed ID: 29363650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human anti-nucleolin recombinant immunoagent for cancer therapy.
    Palmieri D; Richmond T; Piovan C; Sheetz T; Zanesi N; Troise F; James C; Wernicke D; Nyei F; Gordon TJ; Consiglio J; Salvatore F; Coppola V; Pichiorri F; De Lorenzo C; Croce CM
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9418-23. PubMed ID: 26170308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shear stress regulation of miR-93 and miR-484 maturation through nucleolin.
    Gongol B; Marin T; Zhang J; Wang SC; Sun W; He M; Chen S; Chen L; Li J; Liu JH; Martin M; Han Y; Kang J; Johnson DA; Lytle C; Li YS; Huang PH; Chien S; Shyy JY
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12974-12979. PubMed ID: 31182601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREB1/Lin28/miR-638/VASP Interactive Network Drives the Development of Breast Cancer.
    Hu PC; Li K; Tian YH; Pan WT; Wang Y; Xu XL; He YQ; Gao Y; Wei L; Zhang JW
    Int J Biol Sci; 2019; 15(12):2733-2749. PubMed ID: 31754343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer.
    Zhang M; Yang L; Hou L; Tang X
    Bioengineered; 2021 Dec; 12(2):9239-9250. PubMed ID: 34806925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.